Helen Mossop

4.9k total citations
23 papers, 284 citations indexed

About

Helen Mossop is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Radiation. According to data from OpenAlex, Helen Mossop has authored 23 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 4 papers in Surgery and 4 papers in Radiation. Recurrent topics in Helen Mossop's work include Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Advanced Radiotherapy Techniques (4 papers). Helen Mossop is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Advanced Radiotherapy Techniques (4 papers). Helen Mossop collaborates with scholars based in United Kingdom, United States and Maldives. Helen Mossop's co-authors include Emma Hall, Danny Chan, Dermot Neely, Vijay Kunadian, Sophie Gu, Weiliang Qiu, Jonathan A. Batty, Zafeiris Zafeiriou, Shahneen Sandhu and Joaquı́n Mateo and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Radiology.

In The Last Decade

Helen Mossop

22 papers receiving 283 citations

Peers

Helen Mossop

PRM

RNMI

RADIA

CCM

SURGE

Govind Raghavan United States

Hélèna Huguet France

Pragya Shukla India

Claire Hackett United Kingdom

Públio César Cavalcante Viana Brazil

Paul Y. Song United States

Laura L. Snyder United States

Maseeh uz Zaman Pakistan

Kevin A. Pearlstein United States

Ferenc Rárosi Hungary

Govind Raghavan United States

Helen Mossop

186 ×1.2

PRM

46 ×0.5

RNMI

55 ×1.3

RADIA

19 ×0.6

CCM

78 ×2.4

SURGE

Citations per year, relative to Helen Mossop Helen Mossop (= 1×) peers Govind Raghavan

Countries citing papers authored by Helen Mossop

Since Specialization

Citations

This map shows the geographic impact of Helen Mossop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Mossop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Mossop more than expected).

Fields of papers citing papers by Helen Mossop

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Mossop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Mossop. The network helps show where Helen Mossop may publish in the future.

Co-authorship network of co-authors of Helen Mossop

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Mossop. A scholar is included among the top collaborators of Helen Mossop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Mossop. Helen Mossop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

King, William, Tara Homer, Chris Harding, et al.. (2024). Cost-effectiveness of methenamine hippurate compared with antibiotic prophylaxis for the management of recurrent urinary tract infections in secondary care: a multicentre, open-label, randomised, non-inferiority trial. BMJ Open. 14(4). e074445–e074445. 1 indexed citations

Stocken, Deborah, Helen Mossop, Steff Lewis, et al.. (2024). Good Statistical Practice—development of tailored Good Clinical Practice training for statisticians. Trials. 25(1). 113–113. 2 indexed citations

Jones, James O., Anne Y. Warren, Helen Mossop, et al.. (2024). 75 WIRE: Window of Opportunity Clinical Trials Platform for Evaluation of Novel Treatments Strategies in Renal Cell Cancer. The Oncologist. 29(Supplement_1). S15–S16. 1 indexed citations

Robson, Stephen C., Catherine McParlin, Helen Mossop, et al.. (2021). Ondansetron and metoclopramide as second-line antiemetics in women with nausea and vomiting in pregnancy: the EMPOWER pilot factorial RCT. Health Technology Assessment. 25(63). 1–116. 3 indexed citations

Mossop, Helen, Michael J. Grayling, Ferdia A. Gallagher, et al.. (2021). Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials. British Journal of Cancer. 126(2). 204–210. 1 indexed citations

Mossop, Helen, Vicky Ryan, Jeffrey P. Pearson, et al.. (2019). Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis. Thorax. 74(4). 346–353. 38 indexed citations

Chan, Danny, Sophie Gu, Weiliang Qiu, et al.. (2019). The association between vitamin D status and clinical events in high-risk older patients with non-ST elevation acute coronary syndrome undergoing invasive management. PLoS ONE. 14(6). e0217476–e0217476. 7 indexed citations

Murray, Julia, S. Gulliford, Clare Griffin, et al.. (2019). Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial. Clinical and Translational Radiation Oncology. 21. 77–84. 20 indexed citations

Murray, Julia, Clare Griffin, S. Gulliford, et al.. (2019). A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer. Radiotherapy and Oncology. 142. 62–71. 29 indexed citations

10.

Ali, Ased, Alaa Abouhajar, Catherine Brennand, et al.. (2018). ALternatives To prophylactic Antibiotics for the treatment of Recurrent urinary tract infection in women (ALTAR): study protocol for a multicentre, pragmatic, patient-randomised, non-inferiority trial. Trials. 19(1). 616–616. 16 indexed citations

11.

Granic, Antoneta, Helen Mossop, Gabriella Engström, et al.. (2018). Factors Associated With Physical Performance Measures in a Multiethnic Cohort of Older Adults. Gerontology and Geriatric Medicine. 4. 3693856767–3693856767. 4 indexed citations

12.

Mossop, Helen, Antoneta Granic, Avan Aihie Sayer, et al.. (2017). 41DIFFERENCES IN PHYSICAL PERFORMANCE ACROSS A MULTI-ETHNIC COHORT OF OLDER ADULTS: INSIGHTS FROM THE HEALTHY AGING RESEARCH INITIATIVE. Age and Ageing. 46(suppl_2). ii11–ii13. 1 indexed citations

13.

Murray, Julia, et al.. (2017). Effect of Dose to the Penile Bulb on Erectile Potency (EP) in Prostate Image-guided Radiotherapy (IGRT). Clinical Oncology. 29(3). e86–e86. 1 indexed citations

14.

Mateo, Joaquı́n, Helen Mossop, Jane Goodall, et al.. (2017). Association of changes in circulating cell-free plasma DNA (cfDNA) and circulating tumor cells (CTC) during treatment with clinical outcome from olaparib in castration-resistant prostate cancer (CRPC): Exploratory analyses from the TOPARP-A trial.. Journal of Clinical Oncology. 35(6_suppl). 141–141. 2 indexed citations

15.

Pérez-López, Raquel, Joaquı́n Mateo, Helen Mossop, et al.. (2016). Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot Study. Radiology. 283(1). 168–177. 81 indexed citations

16.

Dearnaley, David P., Isabel Syndikus, Helen Mossop, et al.. (2016). Comparison of hypofractionated high-dose intensity-modulated radiotherapy schedules for prostate cancer: Results from the phase III randomized CHHiP trial (CRUK/06/016).. Journal of Clinical Oncology. 34(2_suppl). 2–2. 11 indexed citations

17.

Dearnaley, David P., Isabel Syndikus, Helen Mossop, et al.. (2015). 8LBA 5 year outcomes of a phase III randomised trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): report from the CHHiP Trial Investigators Group. European Journal of Cancer. 51. S712–S712. 10 indexed citations

18.

Mossop, Helen, et al.. (2015). PO-0720: Patient reported outcomes of overall bowel and urinary bother in the CHHiP trial (CRUK: 8262/A7257). Radiotherapy and Oncology. 115. S355–S356. 1 indexed citations

19.

Mateo, Joaquı́n, Emma Hall, Shahneen Sandhu, et al.. (2014). Antitumour Activity of the Parp Inhibitor Olaparib in Unselected Sporadic Castration-Resistant Prostate Cancer (Crpc) in the Toparp Trial. Annals of Oncology. 25. v1–v1. 10 indexed citations

20.

Blair, Irene V., et al.. (2004). Surveillance of sexually transmitted infections in the West Midlands using anonymised individual patient datasets from genitourinary medicine clinics.. PubMed. 7(2). 112–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact